U-Blot® Human ErbB2/Her2 & CD3 epsilon Antibody (Trastuzumab & UCHT1)Cat. No. WA3856Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Human ErbB2/Her2 & CD3 epsilon Antibody (Trastuzumab & UCHT1)Cat. No. WA3856
U-Blot® Research Grade ZubotamigCat. No. WA3855
U-Blot® Research Grade ZuberitamabCat. No. WA3854
U-Blot® Research Grade ZovostotugCat. No. WA3853
U-Blot® Research Grade zoninterferon alfa-2bCat. No. WA3852
U-Blot® Research Grade ZolimomabCat. No. WA3851
U-Blot® Research Grade ZolbetuximabCat. No. WA3850
U-Blot® Research Grade zocilurtatugCat. No. WA3849
U-Blot® Research Grade ZiralimumabCat. No. WA3848
U-Blot® Research Grade ZinlirvimabCat. No. WA3847
U-Blot® Research Grade zinihyaluronidase alfaCat. No. WA3846
U-Blot® Research Grade ZimberelimabCat. No. WA3845